Dr Iryna Schlackow
Senior Researcher in Health Economics
- Health Economics Research Centre
Iryna Schlackow is a Senior Researcher in Health Economics. Her main area of interest covers questions related to chronic kidney and cardiovascular diseases, such as decision-analytic modelling, assessing long-term health outcomes and cost-effectiveness of interventions, and socioeconomics aspects of the disease. She has worked with large randomised controlled trials (SHARP, REVEAL), meta-analyses of statin trials (CTT) and routine datasets (CPRD, HES). Based on SHARP data, and with the help of collaborators, she has developed the SHARP CKD-CVD model, which projects lifetime cardiovascular event risks, kidney disease projection, (quality-of-life adjusted) survival and healthcare costs based on individual patients’ risk profiles.
Prior to joining the department, Iryna worked as a statistician in the Infectious Diseases and Microbiology group of the Nuffield Department of Medicine, modelling disease trends using routinely collected data. Details of this work could be found here.
Iryna comes from a pure mathematics background and completed a DPhil in Functional Analysis. To maintain her interest in the subject, she also works a Stipendiary Lecturer at Brasenose College teaching a range of first- and second-year pure mathematics papers. For many years she has also taught courses on LaTeX.
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
Schlackow I. et al, (2017), Heart
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
Mihaylova B. et al, (2016), American journal of kidney diseases
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD.
Morton RL. et al, (2016), Am j kidney dis, 67, 31 - 39
The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review.
Morton RL. et al, (2016), Nephrol dial transplant, 31, 46 - 56
Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.
Kent S. et al, (2015), Med decis making, 35, 902 - 911